EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS
https://doi.org/10.21292/2075-1230-2017-95-6-51-58
Abstract
Goal of the study: to investigate the impact of isoniazid combined with silver nanoparticles on the isoniazid resistant strains of tuberculous mycobacteria and the course of experimental of tuberculosis caused by the above strains.
Materials and methods. The electrochemical metal resolution was used to obtain silver nanoparticles, the average size of nanoparticles made 3-60 nm. The investigated concentrations of silver nanoparticles made 5; 25; 50 µg/ml. The isoniazid was used only in one concentration of 1 mg/ml. Totally there were 651 in vitro tests.
The experimental tuberculosis model included infecting mice (totally 68) with two-week virulent multiple drug resistant culture of M. tuberculosis.
Results. In vitro tests proved that isoniazid combined with silver nanoparticles fully or significantly suppressed the growth of MDR TB strain in 49.2% of cases. The minimal inhibitory concentration of nanoparticles in the combination with isoniazid made 2.5 µg/ml and minimal bactericidal concentration made 5 µg/ml. Atomic force microscopy detected the changes in morphometric parameters of MDR tuberculous mycobacteria after exposure to silver nanoparticles combined with isoniazid unlike the use of isoniazid only or silver nanoparticles. When treating experimental tuberculosis, survival rates and histological tests of the lung tissue confirmed that the combination of isoniazid and silver nanoparticles was preferable compared to the single use of the above components.
About the Authors
A. V. Zаkhаrov
Regional Clinical Tuberculosis Hospital
Russian Federation
Russian Federation
Andrey V. Zakharov - Candidate of Medical Sciences, Head of Pulmonary Tuberculosis Department.
43, Sobinova St., Yaroslavl, 150000, Phone/Fax: +7 (4852) 43-97-25
A. E. Ergeshov
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Atadzhan E. Ergeshov - Doctor of Medical Sciences, Professor, Director.
2, Yauzskaya Alleya, Moscow, 107564, Phone: +7 (499) 785-90-19A. L. Khokhlov
Yaroslavl State Medical University
Russian Federation
Russian Federation
Aleksandr L. Khokhlov - Doctor of Medical Sciences, Professor, Correspondent Member of RAMS, Head of Clinical Pharmacology Department with Post-Graduate Training Course.
5, Revolyutsionnaya St., Yaroslavl, 150000 , Phone: +7 (4852) 45-84-61
B. S. Kibrik
Yaroslavl State Medical University
Russian Federation
Russian Federation
Boris S. Kibrik - Doctor of Medical Sciences, Professor of Tuberculosis Department.
5, Revolyutsionnaya St., Yaroslavl, 150000 , Phone: +7 (4852) 48-41-38
References
1. Egorova E.M., Revina А.А., Rostovschikova T.N., Kiseleva O.I. Bactericidal and catalytic properties of stable metal nanoparticles in inverted micelles. Vestn. Mosk. Un-ta. Ser. 2. Khimiya, 2001, vol. 42, no. 5, pp. 332-338. (In Russ.)
2. Zakharov А.V., Kibrik B.S., Kreytsberg G.N. Evaluation of bacteriostatic and bactericidal parameters of anti-tuberculosis nanocomposite materials based on silver nanoparticles. V kn. XVII Rossiyskiy natsionalny kongress «Chelovek i lekarstvo» po boleznyam organov dykhaniya: Sbornik materialov kongressa. Tezisy dokladov. [Abst. book of the XVIIth Russian National Congress on Man and Drug. Respiratory Diseases]. Moscow, 2010, pp. 618. (In Russ.)
3. Zakharov А.V., Kibrik B.S., Pavlov А.V. Treatment efficiency of experimental tuberculosis with the use of silver nanoparticles. Tuberculosis and Lung Diseases, 2011, no. 4, pp. 151-152. (In Russ.)
4. Kibrik B.S., Pavlov А.V., Zakharov А.V. et al. Experimental justification of overcoming the resistance of tuberculous mycobacteria by the nanocomposite material consisting of isoniazid and sliver nanoparticles. Eksperimental. i Klinich. Farmakologiya, 2011, vol. 74, no. 4, pp. 24-26. (In Russ.)
5. Krutyakov Yu.А., Kudrinskiy А.А., Olenin А.Yu., Lisichkin G.V. Synthesis and properties of silver nanoparticles: achievements and prospectives. Uspekhi Khimii, 2008, no. 3, pp. 242-269. (In Russ.)
6. Radtsig M.А. Vzaimodeystvie kletok bakteriy s soedineniyami serebra i zolota: vliyanie na rost, obrazovanie bioplenok, mekhanizmy deystviya, biogenez nanochastits Diss. kand. med. nauk. [Interaction of bacterial cells with silver and gold compounds: impact on their growth, formation of biofilms, action mechanisms, biogenesis of nanoparticles. Cand. Diss.]. Moscow, 2013, 24 p.
7. Radtsig M.А., Khmel I.А. The specific antibacterial action of silver nanoparticles. 3-y Evraziyskiy kongress po meditsinskoy fizike i inzhenerii «Meditsinskaya fizika – 2010». [The 3rd Eurasian Congress on Medical Physics and Engineering 2010]. Moscow, 2010, June 21-25, 2016 vol. 3, Part on Nanotechnologies in Medicine. pp. 324-326. (In Russ.)
8. Federalnye klinicheskiye rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya s mnozhestvennoy lekarstennoy ustoichivostyu vozbuditelya. [Federal clinical recommendations for diagnosis and treatment of respiratory tuberculosis with multiple drug resistance]. 3rd Edition. Approved at the Xth Meeting of the Russian Society of Phthisiologists as of 28.05.2015 and Profile Commission in Phthisiology by the Russian Ministry of Health as of 13.11.2015.
9. Yaminskiy I.V. Vzglyad v mikromir: ot atomov i molekul – do zhivykh kletok. [Insight into microworld – from atoms and molecules to living cells]. Moscow, Nauka Publ., 2006, 106 p.
10. Anh-Tuan Le, Huy P.T., Tran Quang Huy et al. Photochemical synthesis of silver nanoparticles possessing high anti-bacterial action. Ros. Nanotekhnologii, 2010, no. 7-8, pp. 125-131. (In Russ.)
Review
For citations:
Zаkhаrov A.V., Ergeshov A.E., Khokhlov A.L., Kibrik B.S. EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS. Tuberculosis and Lung Diseases. 2017;95(6):51-58. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-6-51-58
Views:
1483
Email this article 